VALPROIC ACID AS AN EFFECTIVE TREATMENT FOR SELF-INJURIOUS BEHAVIOR IN A PATIENT WITH WOLF-HIRSCHHORN SYNDROME: A CASE REPORT
Open Access
- 20 May 2025
- journal article
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 6 (2) , 152-156
Abstract
Wolf-Hirschhorn Syndrome (WHS) is a neurodevelopmental disorder (NDD) characterized by a microdeletion, often accompanied by maladaptive behaviors. First-line medical treatment involves antipsychotics; however, when antipsychotics prove insufficient, treatment options become limited. In this case, it was aimed to demonstrate that valproic acid as monotherapy could eliminate maladaptive behaviors in a patient diagnosed with WHS accompanied by self-injurious behavior. A 10-year 4-month-old female patient with WHS exhibited intense self-injurious behaviors. When her demands were not met, she would bang her head against the wall with significant force, risking severe traumatic injury, and bite her hand. She had previously received sufficient dosage and durations of aripiprazole and risperidone treatments without benefit. Valproic acid was initiated at a dose of 400 mg/day in divided doses. After the first month of treatment, the patient ceased the behavior of banging her head. Additionally, the behavior of biting her hand significantly decreased. The Aberrant Behavior Checklist (ABC) score, initially assessed at 51 points, decreased to 28 points after the first month of treatment. The decrease in the ABC score was particularly marked in the subscales of irritability and social withdrawal. This outcome suggests that in patients diagnosed with neurodevelopmental disorders (NDD) where antipsychotics have failed, valproic acid as a mood stabilizer may be beneficial as monotherapy in reducing self-injurious behavior.Keywords
This publication has 5 references indexed in Scilit:
- Management of Self‐injurious Behaviors in Children with Neurodevelopmental Disorders: A Pharmacotherapy OverviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2019
- Prenatal diagnosis of Wolf–Hirschhorn syndrome: from ultrasound findings, diagnostic technology to genetic counselingArchives of Gynecology and Obstetrics, 2018
- Divalproex Sodium vs Placebo for the Treatment of Irritability in Children and Adolescents with Autism Spectrum DisordersNeuropsychopharmacology, 2009
- Update on the clinical features and natural history of Wolf–Hirschhorn (4p‐) syndrome: Experience with 87 patients and recommendations for routine health supervisionAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2008
- Chromosomal disorders associated with epilepsyEpileptic Disorders, 2005